Carrier - based Drug Delivery (Record no. 15185)

MARC details
000 -LEADER
fixed length control field 02120nam a2200181Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140223b2004 xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780841238398
Terms of availability 0.00
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7
Item number CAR
245 ## - TITLE STATEMENT
Title Carrier - based Drug Delivery
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Washington
Name of publisher, distributor, etc American Chemical Society Publication
Date of publication, distribution, etc 2004
300 ## - PHYSICAL DESCRIPTION
Extent 346p
440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE
Title ACS Symposium Series
Volume number/sequential designation 879
9 (RLIN) 18381
500 ## - GENERAL NOTE
General note Carrier Based Drug Delivery is divided into three main sections that cover major carrier systems used to deliver drugs as well as DNA. The first section describes the use of liposomes and tubules as carrier systems. The eight chapters in this section report the use of stimuli-responsive liposomes and liposome-polymer complexes in drug and DNA delivery, the application of neutral liposomes in gene transfer, and the use of niosomes in the delivery of poorly soluble drugs. The role of vesicle shape in delivery is discussed, followed by two reviews on the use of microtubules and templated nanotubes for the delivery and separation of bioactives. The second section is devoted to the use of polymeric micelles as targetable pharmaceutical carriers, novel therapeutics in drug delivery, and endosomolytic agents for gene delivery. The section concludes with a chapter on the use of ultrasound to improve the efficiency of polymeric micelles as carriers. The third section presents nine chapters on the use of micro- and nanoparticulate carriers in drug delivery. These chapters address methods to prepare precise micro- and nanoparticles, the utilization of lipids in peptide and protein release, and the construction of nanocontainers, either by stabilization of liposomal templates or by layer-by-layer deposition of polymers around colloidal templates. The reduction or prevention of burst release from matrices is discussed, as well as the use of mucoadhesion and mechanical adhesion for localized nasal and peroral delivery of actives.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
Personal name Drug Delivery
9 (RLIN) 18382
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Svenson, Sonke
Relator term Editor
9 (RLIN) 18383
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Item type Book
Call number prefix 615.7
Call number suffix CAR
995 ## - RECOMMENDATION 995 [LOCAL, UNIMARC FRANCE]
Origin of item (home branch) (free text) Pharmacy Reference
Genre P0005622
Section 615.7
Recipient parent organisation code P0005622

No items available.

© 2025 by NIMA Knowledge Centre, Ahmedabad.
Koha version 24.05